During Friday’s Current trade, Shares of Iteris Inc (NYSEMKT:ITI), lost -0.57% to $1.75.
Iteris, Inc. (ITI), a leader in providing information solutions to the transportation and agriculture markets, has partnered with Conservis Corp., the industry leader in farm administration software, to integrate Iteris’ ClearAg Visualization Components and Advisory Services into Conservis’ next-generation farm administration information system (FMIS) platform.
Conservis’ FMIS platform manages more than $8 billion of farm assets at all stages of production, providing growers with real-time administration such as planning, purchasing, planting, harvesting, and marketing control. Through this integration with Iteris, Conservis customers will also be able to access ClearAg’s global weather, water, soil, and crop health advisory information through the embedded visualization components in Conservis’ farm administration dashboard.
Iteris, Inc. provides intelligent information solutions to the traffic administration market worldwide. It operates in three segments: Roadway Sensors, Transportation Systems, and Performance Analytics. The Roadway Sensors segment offers a range of vehicle detection systems for traffic intersection control, incident detection, and roadway traffic data collection applications. Its products comprise Vantage video detection system to detect vehicle presence at intersections; VantageView software to manage video detection assets remotely; Vantage Vector vehicle detection sensor with stop bar detection, advanced-zone detection, and sensing capabilities; SmartCycle for differentiating bicycles and other vehicles; and VersiCam integrated camera and processor video detection system for smaller intersections, in addition to SmartSpan, Velocity, P10, P100, and Abacus products
Shares of Amedica Corporation (NASDAQ:AMDA), inclined 36.67% to $0.743, during its current trading session.
Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, declared that responses to the U.S. Food and Drug Administration (“FDA”) inquiries regarding the Company’s cervical composite silicon nitride interbody device were presented to the FDA on June 30, 2015. Additionally, the Company has received feedback from the FDA regarding its wear testing femoral head protocols.
Submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding (“Valeo C CsC”), which was presented in the first quarter of 2015, relates to the Company’s CASCADE clinical trial of its composite silicon nitride spinal interbody devices. Since submission, the Company received a list of questions from the FDA requesting additional information pertaining to the product’s clinical performance data, in addition to indications for use and device description. The Company has responded to the questions and now awaits clearance of the Class II medical device for commercial distribution or additional communication from the FDA.
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. It offers Valeo silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; and a line of non-silicon nitride spinal fusion products.
Quiksilver, Inc. (NYSE:ZQK), during its Friday’s current trading session decreased -1.73% to $0.517.
Quiksilver, Inc. (ZQK) declared that on July 10, 2015, the Company was notified by the New York Stock Exchange (“NYSE”) that the Company’s common stock is not in compliance with the NYSE’s continued listing standard that requires a minimum average closing price of $1.00 per share over a period of 30 successive trading days.
Under the NYSE’s rules, the Company has a period of six months from the date of the NYSE notice to bring its 30-day average share price back above $1.00. However, if the Company determines to remedy the non-compliance by taking action that will require shareholder approval, such as a reverse stock split, the Company must obtain shareholder approval of such action by no later than its next annual meeting, and implement such action promptly thereafter. During this period, the Company’s common stock will continue to be traded on the NYSE, subject to the Company’s compliance with other NYSE listing requirements. The Company will notify the NYSE of its intent to cure this noncompliance.
Quiksilver, Inc. designs, develops, and distributes branded apparel, footwear, accessories, and related products primarily for men, women, and children. The company provides its products for various activities, counting casual and outdoor lifestyle associated with surfing, skateboarding, snowboarding, BMX and motocross, rally car, and other activities.
Finally, Qorvo Inc (NASDAQ:QRVO), decreased -1.19%, to $74.27.
Qorvo(TM) (QRVO), a leading provider of core technologies and RF solutions for mobile, infrastructure and aerospace/defense applications, will host a conference call to review fiscal 2016 first quarter financial results on Wednesday, July 29, 2015, at 5:00 p.m. (ET). The conference call will be webcast live on the Company’s web site at the following URL: http://www.qorvo.com (under “Investors”).
Qorvo, Inc. provides technologies and radio frequency (RF) solutions for mobile, infrastructure, defense, and aerospace applications in the United States and internationally. The company operates through Mobile Products, and Infrastructure and Defense Products segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
